TR199900548A3 - Düsük kesme kuvvetli taneleme kullanilarak dozaj birimlerinin yapimi. - Google Patents
Düsük kesme kuvvetli taneleme kullanilarak dozaj birimlerinin yapimi.Info
- Publication number
- TR199900548A3 TR199900548A3 TR1999/00548A TR9900548A TR199900548A3 TR 199900548 A3 TR199900548 A3 TR 199900548A3 TR 1999/00548 A TR1999/00548 A TR 1999/00548A TR 9900548 A TR9900548 A TR 9900548A TR 199900548 A3 TR199900548 A3 TR 199900548A3
- Authority
- TR
- Turkey
- Prior art keywords
- production
- dosage units
- low shear
- shear granulation
- granulation
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
- A61K31/568—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in positions 10 and 13 by a chain having at least one carbon atom, e.g. androstanes, e.g. testosterone
- A61K31/569—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in positions 10 and 13 by a chain having at least one carbon atom, e.g. androstanes, e.g. testosterone substituted in position 17 alpha, e.g. ethisterone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/575—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of three or more carbon atoms, e.g. cholane, cholestane, ergosterol, sitosterol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1682—Processes
- A61K9/1694—Processes resulting in granules or microspheres of the matrix type containing more than 5% of excipient
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2095—Tabletting processes; Dosage units made by direct compression of powders or specially processed granules, by eliminating solvents, by melt-extrusion, by injection molding, by 3D printing
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP98200790 | 1998-03-12 |
Publications (2)
Publication Number | Publication Date |
---|---|
TR199900548A3 true TR199900548A3 (tr) | 1999-10-21 |
TR199900548A2 TR199900548A2 (tr) | 1999-10-21 |
Family
ID=8233460
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
TR1999/00548A TR199900548A2 (tr) | 1998-03-12 | 1999-03-12 | Düsük kesme kuvvetli taneleme kullanilarak dozaj birimlerinin yapimi. |
Country Status (15)
Country | Link |
---|---|
US (1) | US6054145A (tr) |
JP (1) | JPH11319035A (tr) |
KR (1) | KR19990077775A (tr) |
CN (1) | CN1238948A (tr) |
AR (1) | AR016454A1 (tr) |
AU (1) | AU2118199A (tr) |
BR (1) | BR9904552A (tr) |
CA (1) | CA2265211A1 (tr) |
CZ (1) | CZ88899A3 (tr) |
HU (1) | HUP9900598A2 (tr) |
IL (1) | IL128818A0 (tr) |
NO (1) | NO991195L (tr) |
PL (1) | PL331961A1 (tr) |
SG (1) | SG72938A1 (tr) |
TR (1) | TR199900548A2 (tr) |
Families Citing this family (14)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP1177726A1 (en) * | 2000-08-04 | 2002-02-06 | Aventis Animal Nutrition S.A. | Process for the production of granules of methionine |
JP2002326925A (ja) * | 2001-04-27 | 2002-11-15 | Asahi Breweries Ltd | 造粒物および錠剤の製造方法 |
DK1670440T3 (da) * | 2003-09-29 | 2014-07-07 | Novo Nordisk As | HRT formuleringer |
ES2933479T3 (es) * | 2003-09-29 | 2023-02-09 | Novo Nordisk Healthcare Ag | Estabilidad mejorada de formulaciones de progestágenos |
TWI547431B (zh) * | 2004-06-09 | 2016-09-01 | 史密斯克萊美占公司 | 生產藥物之裝置及方法 |
US20060002986A1 (en) * | 2004-06-09 | 2006-01-05 | Smithkline Beecham Corporation | Pharmaceutical product |
US8715724B2 (en) * | 2004-10-29 | 2014-05-06 | Mayne Pharma International Pty Ltd | Tabletting process |
US20070036859A1 (en) * | 2005-08-11 | 2007-02-15 | Perry Ronald L | Sustained release antihistamine and decongestant composition |
EP2040718B1 (en) * | 2006-06-28 | 2017-12-27 | Emisphere Technologies, Inc. | Gallium nitrate formulations |
CN101810706B (zh) * | 2009-05-26 | 2011-03-16 | 成都地奥制药集团有限公司 | 一种低剂量地榆固体制剂的制备方法 |
US20170182070A1 (en) | 2014-10-08 | 2017-06-29 | Mayne Pharma International Pty Ltd. | Controlled Release Doxycycline |
EP3843889A1 (en) * | 2018-08-30 | 2021-07-07 | Boehringer Ingelheim International GmbH | Novel, lean and environment-friendly granulation method |
SG11202113359RA (en) | 2019-07-01 | 2021-12-30 | Oakwood Laboratories LLC | System and method for making microspheres and emulsions |
US11330838B2 (en) | 2019-07-19 | 2022-05-17 | R. J. Reynolds Tobacco Company | Holder for aerosol delivery device with detachable cartridge |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0300523B1 (en) * | 1987-07-06 | 1991-08-14 | Akzo N.V. | Pharmaceutical dosage unit for the prevention or treatment of climacteric complaints |
US5098714A (en) * | 1989-11-16 | 1992-03-24 | Alza Corporation | Osmotic, oral dosage form for fertility control |
US5266331A (en) * | 1991-11-27 | 1993-11-30 | Euroceltique, S.A. | Controlled release oxycodone compositions |
WO1996009056A1 (en) * | 1994-09-22 | 1996-03-28 | Akzo Nobel N.V. | Process of making dosage units by wet granulation |
IL115445A (en) * | 1994-10-17 | 1999-08-17 | Akzo Nobel Nv | Solid pharmaceutical compositions comprising low dosage active ingredient oil and excipient capable of binding water and their preparation |
-
1999
- 1999-03-04 IL IL12881899A patent/IL128818A0/xx unknown
- 1999-03-05 JP JP11058990A patent/JPH11319035A/ja active Pending
- 1999-03-08 SG SG1999001527A patent/SG72938A1/en unknown
- 1999-03-11 KR KR1019990008039A patent/KR19990077775A/ko not_active Application Discontinuation
- 1999-03-11 BR BR9904552-4A patent/BR9904552A/pt not_active Application Discontinuation
- 1999-03-11 CN CN99105641A patent/CN1238948A/zh active Pending
- 1999-03-11 HU HU9900598A patent/HUP9900598A2/hu unknown
- 1999-03-11 NO NO991195A patent/NO991195L/no not_active Application Discontinuation
- 1999-03-11 AR ARP990101041A patent/AR016454A1/es unknown
- 1999-03-11 CA CA002265211A patent/CA2265211A1/en not_active Abandoned
- 1999-03-12 CZ CZ99888A patent/CZ88899A3/cs unknown
- 1999-03-12 AU AU21181/99A patent/AU2118199A/en not_active Abandoned
- 1999-03-12 TR TR1999/00548A patent/TR199900548A2/tr unknown
- 1999-03-12 US US09/267,320 patent/US6054145A/en not_active Expired - Fee Related
- 1999-03-12 PL PL99331961A patent/PL331961A1/xx unknown
Also Published As
Publication number | Publication date |
---|---|
CZ88899A3 (cs) | 1999-11-17 |
NO991195L (no) | 1999-09-13 |
CA2265211A1 (en) | 1999-09-12 |
JPH11319035A (ja) | 1999-11-24 |
KR19990077775A (ko) | 1999-10-25 |
HU9900598D0 (en) | 1999-05-28 |
HUP9900598A2 (hu) | 2001-06-28 |
NO991195D0 (no) | 1999-03-11 |
CN1238948A (zh) | 1999-12-22 |
AU2118199A (en) | 1999-09-23 |
BR9904552A (pt) | 2000-09-26 |
SG72938A1 (en) | 2000-05-23 |
TR199900548A2 (tr) | 1999-10-21 |
AR016454A1 (es) | 2001-07-04 |
PL331961A1 (en) | 1999-09-13 |
IL128818A0 (en) | 2000-01-31 |
US6054145A (en) | 2000-04-25 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ID26420A (id) | Indolinon-indolinon tersubstitusi baru, pembuatannya dan penggunaannya sebagai komposisi-komposisi farmasi | |
IS6624A (is) | Samfelld framleiðsla á lyfjafræðilegri kornamyndun | |
MA26937A1 (fr) | Nouvelle composition pharmaceutique. | |
TR199901077A3 (tr) | Ispençiyari formülasyonlar. | |
ID26334A (id) | Morfolinol yang aktif secara farmasi | |
DE69927803D1 (de) | Imidazo-pyridin verbindungen, die die sekretion von magensäure hemmen. | |
MA25413A1 (fr) | Fabrication de micromousse therapeutique. | |
ID27415A (id) | Komposisi farmaseutik | |
DK1208864T3 (da) | Forbedringer til lægemiddelafgivelsesindretninger | |
MA26812A1 (fr) | Pyrimidine-2,4,6-triones inhibitrices de metalloproteinases | |
ID29262A (id) | Komposisi farmasi | |
NO992692L (no) | Nefadozon doseringsform | |
DK1466615T3 (da) | Farmaceutisk præparat | |
TR199900548A3 (tr) | Düsük kesme kuvvetli taneleme kullanilarak dozaj birimlerinin yapimi. | |
DZ3155A1 (fr) | Nouvelle composition pharmaceutique. | |
NO994294D0 (no) | Tablett til Õ svelge omfattende paracetamol | |
NO20005179D0 (no) | Medikament behandling | |
IT1303694B1 (it) | Produzione di perfluoroalchilvinileteri. | |
IS5600A (is) | Aðferð til framleiðslu á vernduðu 4-amínómetýl-pýrrólidín-3-óni. | |
NO20010089D0 (no) | Farmasöytisk levotyroksinpreparat | |
TR199801871A3 (tr) | Bifenilsulfonilsiyanamidler üretim yöntemi ve ilaç olarak kullanimlari. | |
DZ3164A1 (fr) | Nouvel agent pharmaceutique. | |
IT245517Y1 (it) | Mescolatrice per impianti per la fabbricazione di blocchi di materialelapideo. | |
NO20021866L (no) | Ciclesonid-inneholdende vandig farmasoytisk blanding | |
ATE283629T1 (de) | Deltamethrinhaltiges, wasserdispergierbares granulat |